CIGNA Member Correction

CIGNA members: Please note that you may receive a letter in the mail stating that The Dermatology Center of Indiana is no longer in your network. This communication from CIGNA is incorrect and we would like to reassure you that we are still in network with CIGNA. We look forward to continuing to service you and your family for all your dermatology needs.

2019

Ichthyosis Vulgaris
Sponsor: Crown
A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Urea
Cream, 40% applied twice-daily for 6 weeks in subjects with Ichthyosis Vulgaris
Phase:
Start Date: 1/2019
End Date: Ongoing

Atopic Dermatitis
Sponsor: AOBiome
An open-label, multicenter, Phase Ib study of B244 delivered as a topical spray to assess safety in pediatric subjects ages 2 to 17 years with atopic dermatitis
2-17 years
Phase: 1b
Start Date: 1/2019
End Date: Ongong

Plaque Psoriasis
Sponsor: Lilly
A 24-Week Multicenter, Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis
Phase: 4
Start Date: 1/2019
End Date: Ongoing

Palmar Hyperhidrosis
Sponsor: Dermira
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium
Cloth, 2.4% in Patients with Palmar Hyperhidrosis
Phase: 2
Start Date: 2/2019
End Date: Ongoing

Atopic Dermatitis
Sponsor: Leo Pharma
An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clinical trials
Phase: 3
Start Date: 3/2019
End Date: Ongoing

Plaque Psoriasis
Sponsor: Therapeutics
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Proof of Concept Comparison Study of the Safety and Efficacy of DUR-928 Topical Solution with Occlusion in Subjects with Mild to Moderate Plaque
Psoriasis
Phase:
Start Date: 3/2019
End Date: Ongoing